Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Journal of Ovarian Research
|
August 11, 2020
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
Wei Chen, Siyuan Zhong, Boer Shan, et al.
Environmental Science and Pollution Research International
|
May 13, 2022
Data-driven evaluation and optimization of the sustainable development of the logistics industry: case study of the Yangtze River Delta in China
Heping Ding, Yujia Liu, Yingyan Zhang, et al.
Gynecologic Oncology
|
May 11, 2024
Prognostic factors of 87 ovarian yolk sac tumor (OYST) patients and molecular characteristics of persistent and recurrent OYST
Shanhui Liang, Huijuan Ge, Shuling Zhou, et al.
Annals of Medicine
|
April 8, 2026
Comparison of chemotherapeutic combination therapy, dosing frequency and dosing sequence for the adjuvant treatment of early-stage breast cancer: a network meta-analysis
Linxiaoxi Ma, Wenjia Zuo, Yizi Zheng, et al.
Breast (Edinburgh, Scotland)
|
December 19, 2022
Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer
Shuling Zhou, Ting Liu, Xiaying Kuang, et al.
Oncotarget
|
May 14, 2016
HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
Anqi Li, Zebing Liu, Ming Li, et al.
BMC Cancer
|
July 13, 2023
HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
Mengyuan Cai, Ming Li, Hong Lv, et al.
Food & Function
|
December 23, 2024
Glycosylation of oyster peptides by COS ameliorates zinc deficiency-induced syndromes: intestinal inflammation and imbalance of the gut microbiota <i>in vivo</i>
Xuening Yu, Guang Li, Shuling Zhou, et al.
Oncotarget
|
May 5, 2017
Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
Anqi Li, Zebing Liu, Ming Li, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
April 18, 2018
Illusion Thermotics
Run Hu, Shuling Zhou, Ying Li, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Journal of Ovarian Research
|
August 11, 2020
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
Wei Chen, Siyuan Zhong, Boer Shan, et al.
Environmental Science and Pollution Research International
|
May 13, 2022
Data-driven evaluation and optimization of the sustainable development of the logistics industry: case study of the Yangtze River Delta in China
Heping Ding, Yujia Liu, Yingyan Zhang, et al.
Gynecologic Oncology
|
May 11, 2024
Prognostic factors of 87 ovarian yolk sac tumor (OYST) patients and molecular characteristics of persistent and recurrent OYST
Shanhui Liang, Huijuan Ge, Shuling Zhou, et al.
Annals of Medicine
|
April 8, 2026
Comparison of chemotherapeutic combination therapy, dosing frequency and dosing sequence for the adjuvant treatment of early-stage breast cancer: a network meta-analysis
Linxiaoxi Ma, Wenjia Zuo, Yizi Zheng, et al.
Breast (Edinburgh, Scotland)
|
December 19, 2022
Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer
Shuling Zhou, Ting Liu, Xiaying Kuang, et al.
Oncotarget
|
May 14, 2016
HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
Anqi Li, Zebing Liu, Ming Li, et al.
BMC Cancer
|
July 13, 2023
HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
Mengyuan Cai, Ming Li, Hong Lv, et al.
Food & Function
|
December 23, 2024
Glycosylation of oyster peptides by COS ameliorates zinc deficiency-induced syndromes: intestinal inflammation and imbalance of the gut microbiota <i>in vivo</i>
Xuening Yu, Guang Li, Shuling Zhou, et al.
Oncotarget
|
May 5, 2017
Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
Anqi Li, Zebing Liu, Ming Li, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
April 18, 2018
Illusion Thermotics
Run Hu, Shuling Zhou, Ying Li, et al.
Page
of 7